Results: 4661

Challenges in the development and implementation of the National Comprehensive Cancer Control Program in Mexico

Salud pública Méx; 58 (2), 2016
Abstract Chronic noncommunicable diseases (NCDs), including cancer, have become the leading cause of human morbidity and mortality. In Mexico, cancer is the third leading cause of death, with a high incidence among the economically active population, a high proportion of advanced stages at diagnosis and ...

Hospitalization and mortality in Mexico due to breast cancer since its inclusion in the catastrophic expenditures scheme

Salud pública Méx; 58 (2), 2016
Abstract Objective: To compare trends in hospital discharges and mortality due to breast cancer (BC) in Mexico from 2004 to 2012 by insurance condition before and after incorporating BC comprehensive treatment into the System of Social Protection in Health (Sistema de Protrección Social en Salud, SPSS)...

Historical distribution of central nervous system tumors in the Mexican National Institute of Neurology and Neurosurgery

Salud pública Méx; 58 (2), 2016
Abstract Objective: To determine the frequency of central nervous system (CNS) tumors in the first fifty years of the National Institute of Neurology and Neurosurgery of Mexico Manuel Velasco Suárez (Instituto Nacional de Neurología y Neurocirugía de México, INNN) from 1965 to 2014. Materials and m...

Epidemiological overview, advances in diagnosis, prevention, treatment and management of epithelial ovarian cancer in Mexico

Salud pública Méx; 58 (2), 2016
Abstract The epithelial ovarian cancer (EOC) has been underdiagnosed because it does not have a specific clinical presentation, and the signs and symptoms are similar to the irritable bowel syndrome and pelvic inflammatory disease. EOC is less common than breast and cervical cancer, but it is more lethal...

HPV vaccination impact on a cervical cancer screening program: methods of the FASTER-Tlalpan Study in Mexico

Salud pública Méx; 58 (2), 2016
Abstract Objective: To outline the design of a clinical trial to evaluate the impact of HPV vaccination as part of a hrHPV-based primary screening program to extend screening intervals. Materials and methods: A total of 18,000 women aged 25-45 years, attending the regular cervical cancer-screening prog...

Proposals for the prevention of lung cancer in the health system of Mexico

Salud pública Méx; 58 (2), 2016
Abstract The management of lung cancer is challenging. However, nowadays the main goal is to achieve a significant overall survival accompanied by a good quality of life. Because smoking is associated with up to 71% of cancer deaths, the first policy that should be established is one that promotes strate...

The burden of cancer in Mexico, 1990-2013

Salud pública Méx; 58 (2), 2016
Abstract: Objective: To analyze mortality and incidence for 28 cancers by deprivation status, age and sex from 1990 to 2013. Materials and methods: The data and methodological approaches provided by the Global Burden of Disease (GBD 2013) were used. Results: Trends from 1990 to 2013 show important cha...

Estimating the indirect costs associated with the expected number of cancer cases in Mexico by 2020

Salud pública Méx; 58 (2), 2016
Abstract Objective: To estimate the indirect costs generated by adults with cancer in Mexico from 2002-2020. Materials and methods: Using information from national sources and the national cancer incidence from GLOBOCAN, we estimated income lost due to premature death (ILPD), short-term benefits (STBs)...

Integrated oncology and palliative care: five years experience at the National Cancer Institute of Mexico

Salud pública Méx; 58 (2), 2016
Abstract Under the national plan for addressing cancer, prevention and detection play important roles. However, the cost of treatments and late diagnosis represent a significant burden on health services. At the National Cancer Institute, more than half of patients present with tumors in advanced stages,...